Best Medical Device Development Companies

Orthogonal vs Jabil Healthcare: full comparison for 2026

Quick verdict

Orthogonal (4.2/5) edges ahead of Jabil Healthcare (3.8/5) overall. Orthogonal is the better choice for SaMD and device companion apps. Jabil Healthcare is the stronger option for global production capacity for cleared devices. The right choice depends on your project size, budget, and required tech stack.

Orthogonal vs Jabil Healthcare: head-to-head summary

Criterion Orthogonal Jabil Healthcare
Founded 1998 1966
HQ Chicago, IL, USA St. Petersburg, FL, USA
Team size 11–60 ~20,000 (healthcare)
Rating 4.2 / 5 3.8 / 5
Primary differentiator Agile delivery adapted to FDA-regulated software, focused on the app and cloud side of connected devices Global scale, supply chain and FDA-registered production for established medical device brands
Pricing model Time and materials, dedicated team Manufacturing supply agreement, NPI contract
Min. engagement Not disclosed Not disclosed
Primary tech stack iOS, Android, Cloud (AWS/Azure) Injection molding, Automated assembly, PCB assembly
Industries served Digital health, Wearables & remote monitoring, Diagnostics & lab devices Surgical & robotics, Drug delivery, Wearables & remote monitoring, Consumer health

Orthogonal vs Jabil Healthcare: overview

Orthogonal

Orthogonal is a Chicago software company founded in 1998 and led by founder and CEO Bernhard Kappe, with its office in the Merchandise Mart. It builds Software as a Medical Device (SaMD), digital therapeutics and the mobile and cloud software that connects to medical devices, working with venture-backed startups as well as established medtech and pharma companies. Directory listings describe ISO 13485 and HIPAA compliance and Class I–III experience. Team size estimates vary widely, from about 11 to 60 people.

Jabil Healthcare

Jabil Healthcare was formed in 2020 when Jabil combined its Nypro business with its orthopedics, spine and trauma units. At launch it had nearly 20,000 employees and more than 35 sites, and its factories producing finished medical devices are FDA registered. It covers minimally invasive devices, surgical robotics, complex catheters, diabetes care and consumer health, and the acquisition of CDMO Pii extended it into drug development and aseptic fill-finish. Jabil reported $8.3 billion in company-wide revenue for its second fiscal quarter of 2026.

Services and capabilities: Orthogonal vs Jabil Healthcare

Capability Orthogonal Jabil Healthcare
Electronics & PCB design ✗ ✓
Firmware & embedded software ✗ ✗
SaMD & companion apps ✓ ✗
Connected devices & IoT ✓ ✗
Industrial design & human factors ✗ ✗
Mechanical engineering ✗ ✓
Device cybersecurity ✓ ✗
Regulatory & QMS support ✓ ✓
Manufacturing & scale-up ✗ ✓

Tech stack comparison: Orthogonal vs Jabil Healthcare

Framework / platform Orthogonal Jabil Healthcare
Embedded C/C++ N/A N/A
Embedded Linux N/A N/A
RTOS N/A N/A
BLE ✓ N/A
Cloud (AWS/Azure) ✓ N/A
IEC 62304 ✓ N/A
ISO 14971 ✓ N/A
ISO 13485 QMS N/A ✓
Qt N/A N/A

Pricing comparison: Orthogonal vs Jabil Healthcare

Criterion Orthogonal Jabil Healthcare
Minimum engagement Not disclosed Not disclosed
Engagement models Dedicated team, Time & materials Manufacturing contract
Rate transparency Not public Not public
Price tier Mid-market Mid-market

Target audience comparison: Orthogonal vs Jabil Healthcare

Dimension Orthogonal Jabil Healthcare
Best company size Startup to mid-market Startup to mid-market
Best industries Digital health, Wearables & remote monitoring, Diagnostics & lab devices Surgical & robotics, Drug delivery, Wearables & remote monitoring
Best use cases Building a mobile app that controls a Class II device, Developing a digital therapeutic for FDA clearance Scaling production of a cleared diabetes device, Global manufacturing of a surgical robotics subsystem
Typical project type Dedicated team Manufacturing contract

Orthogonal vs Jabil Healthcare: pros and cons

Orthogonal
+ Focused on regulated medical software for more than a decade
+ Publishes practical guidance on agile methods under FDA rules, a sign of real process experience
+ Strong on mobile apps that talk to devices over BLE
+ Small enough for direct access to senior people
- No hardware or firmware design
- Small team limits how many parallel workstreams it can staff
- Team size data is inconsistent across sources
Jabil Healthcare
+ One of the largest healthcare manufacturing networks in the world
+ FDA-registered sites for finished devices
+ Strong supply chain management during component shortages
+ Covers drug delivery through the Pii acquisition
- Built for production volume; early design and invention are outside its main business
- Small companies may struggle to get attention
- Engineering support is tied to manufacturing programs

Who should choose Orthogonal?

A typical fit: building a mobile app that controls a Class II device.

Agile delivery adapted to FDA-regulated software, focused on the app and cloud side of connected devices. Minimum engagement is not publicly disclosed. Works best with clients in Digital health, Wearables & remote monitoring, Diagnostics & lab devices.

Who should choose Jabil Healthcare?

A typical fit: scaling production of a cleared diabetes device.

Global scale, supply chain and FDA-registered production for established medical device brands. Minimum engagement is not publicly disclosed. Works best with clients in Surgical & robotics, Drug delivery, Wearables & remote monitoring, Consumer health.

Decision matrix: Orthogonal vs Jabil Healthcare

Your situation Recommended choice
You need full-ownership delivery on a defined project scope Both offer fixed-price models
You need a large dedicated team for an ongoing programme Orthogonal
Your budget is at the lower end Compare: Orthogonal (Not disclosed) vs Jabil Healthcare (Not disclosed)
You need specialist depth in a specific vertical Jabil Healthcare
You need staff augmentation or team extension Neither; consider alternatives that offer staff aug
You need consulting before committing to a build Both may offer discovery engagements

Use case fit: Orthogonal vs Jabil Healthcare

Use case Orthogonal fit Jabil Healthcare fit Winner
Building a mobile app that controls a Class II device Strong Limited Orthogonal
Developing a digital therapeutic for FDA clearance Strong Limited Orthogonal
Scaling production of a cleared diabetes device Limited Strong Jabil Healthcare
Global manufacturing of a surgical robotics subsystem Limited Strong Jabil Healthcare

Verdict: Orthogonal vs Jabil Healthcare

Orthogonal (4.2/5) is the stronger overall choice for most Medical Device Development projects. Agile delivery adapted to FDA-regulated software, focused on the app and cloud side of connected devices.

Jabil Healthcare (3.8/5) is worth a look if you need global manufacturing of a surgical robotics subsystem. If your situation matches that, Jabil Healthcare is a competitive option.

Related comparisons

Orthogonal vs Jabil Healthcare FAQ

Is Orthogonal better than Jabil Healthcare?

Orthogonal (4.2/5) scores higher overall, but "better" depends on your use case. Orthogonal's strongest advantage: focused on regulated medical software for more than a decade. Jabil Healthcare's strongest advantage: one of the largest healthcare manufacturing networks in the world.

How do Orthogonal and Jabil Healthcare differ in pricing?

Orthogonal uses time and materials, dedicated team pricing. Jabil Healthcare uses manufacturing supply agreement, npi contract pricing. Neither firm publishes a full rate card; a discovery call is required for project-specific quotes.

Which is better for enterprise: Orthogonal or Jabil Healthcare?

Jabil Healthcare is the larger team and typically the better enterprise-scale choice. For very large programmes, verify team size and compliance coverage directly with each company before shortlisting.

What are the main differences between Orthogonal and Jabil Healthcare?

Orthogonal's primary differentiator is: agile delivery adapted to FDA-regulated software, focused on the app and cloud side of connected devices. Jabil Healthcare's primary differentiator is: global scale, supply chain and FDA-registered production for established medical device brands. They also differ in team size (11–60 vs ~20,000 (healthcare)), minimum engagement (Not disclosed vs Not disclosed), and primary industries served (Digital health, Wearables & remote monitoring vs Surgical & robotics, Drug delivery).

Verify all details directly with each company before making a decision.